AU7715300A - Method of preventing osteoporosis - Google Patents

Method of preventing osteoporosis

Info

Publication number
AU7715300A
AU7715300A AU77153/00A AU7715300A AU7715300A AU 7715300 A AU7715300 A AU 7715300A AU 77153/00 A AU77153/00 A AU 77153/00A AU 7715300 A AU7715300 A AU 7715300A AU 7715300 A AU7715300 A AU 7715300A
Authority
AU
Australia
Prior art keywords
preventing osteoporosis
osteoporosis
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77153/00A
Inventor
Alfred A. Reszka
Gideon A Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7715300A publication Critical patent/AU7715300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU77153/00A 1999-09-27 2000-09-25 Method of preventing osteoporosis Abandoned AU7715300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15623499P 1999-09-27 1999-09-27
US60156234 1999-09-27
PCT/US2000/026357 WO2001022963A1 (en) 1999-09-27 2000-09-25 Method of preventing osteoporosis

Publications (1)

Publication Number Publication Date
AU7715300A true AU7715300A (en) 2001-04-30

Family

ID=22558694

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77153/00A Abandoned AU7715300A (en) 1999-09-27 2000-09-25 Method of preventing osteoporosis

Country Status (2)

Country Link
AU (1) AU7715300A (en)
WO (1) WO2001022963A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2195293T3 (en) 2007-08-22 2014-03-31 Astrazeneca Ab Cycloptopyl amide derivatives
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
RU2012136148A (en) 2010-02-18 2014-03-27 Астразенека Аб NEW CRYSTAL FORM OF THE CYCLOPROPYLBENZAMIDE DERIVATIVE
US9045445B2 (en) 2010-06-04 2015-06-02 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
SG11201407616TA (en) 2012-05-17 2015-03-30 Array Biopharma Inc Process for making hydroxylated cyclopentylpyrimidine compounds
SG11201407591PA (en) 2012-05-17 2015-01-29 Genentech Inc Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
JP6196294B2 (en) 2012-05-17 2017-09-13 ジェネンテック， インコーポレイテッド Process for producing amino acid compounds
WO2013173736A1 (en) 2012-05-17 2013-11-21 Array Biopharma Inc. Process for making hydroxylated cyclopentylpyrimidine compounds
KR102125588B1 (en) 2012-05-17 2020-06-22 제넨테크, 인크. Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof
WO2015070367A1 (en) * 2013-11-12 2015-05-21 Merck Sharp & Dohme Corp. Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11130670A (en) * 1997-10-27 1999-05-18 Oyo Seikagaku Kenkyusho Osteoporosis therapeutic agent
EP1088333A4 (en) * 1998-06-24 2005-08-10 Merck & Co Inc Compositions and methods for inhibiting bone resorption

Also Published As

Publication number Publication date
WO2001022963A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU3867400A (en) Methods of using bioelastomers
EP1143953A3 (en) Method of inhibiting angiogenesis
AU3803600A (en) Method of securing communication
AU2864499A (en) Method of etching
AU2557500A (en) Methods of making compounds
AU1882901A (en) Pointing method
AU1854901A (en) Novel method
AU3091599A (en) Method of making dimethylnaphtalenes
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU7715300A (en) Method of preventing osteoporosis
AU4156200A (en) Method of receiving information
AU2728901A (en) Method of making hydrofluorocarbons
AUPQ388399A0 (en) A method of transformation
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU9119998A (en) Method of time-to-talk calculation
AU5861700A (en) Method of threading
EP1225621A4 (en) Method of etching
AU4598400A (en) Method of treatment
GB9924752D0 (en) Method of construction
AU5552200A (en) Method
AU1478201A (en) Improved method of immunization
AU4585100A (en) Method
AU2355501A (en) Bone cement
AUPP939599A0 (en) Method of rendering
AU1164401A (en) Method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase